Menu
Enrolling by invitation NCT06993402

DESI - Düsseldorfer ESD Study

Observational Oesophageal Tumour Gastric Tumours Duodenal Tumours Colon Tumours

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Oesophageal Tumour, Gastric Tumours, Duodenal Tumours, Colon Tumours. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

DESI- Düsseldorfer ESD Register Study

Overview

Safety and effectiveness of endoscopic submucosal dissection

Detailed description

Background and study objective The standard of care for premalignant and malignant mucosal lesions in the gastrointestinal track with limited submucosal invasion is an endoscopic resection. A curative resection of the neoplasia often necessitates an en-bloc resection, where the resection ends within healthy tissue (R0 resection). Endoscopic submucosal dissection (ESD) is a highly sophisticated resection technique for lesions in the oesophagus, stomach, duodenum, colon and rectum. Multiple studies in Asia already established the safety and efficacy of ESD. In several spezialized centres in the western world the ESD already replaced the endoscopic mucosal resectiona (EMR) as standart of care. The en-bloc resection facilitates an exact histopathological evaluation, thus leading to lower recurrence rates. Besides specified mucosal lesions, there is an increase in the use of ESD to resect expansive and submucosal lesions. Specialised centres like Evangelisches Krankenhaus Düsseldorf have a high number of ESD cases and use ubiquitous in the gastrointestinal tract. Besides the many advantages over EMR there is still the risk of peri- and postinterventional complications with ESD due to the highly demanding technique and the longer procedure duration. This is why patient selection is crucial factor (in this study). To evaluate the safety and efficacy of ESD more prospective data analysis in western centres are necessary. This data will be useful to develop new approaches to improve the method concerning safety and efficacy and patient selection.

Primary outcome measures

  • Technical success rate [Time frame: during the procedure]
  • Complication rate [Time frame: through study completion, an average of 5 years]
  • Histopahological result [Time frame: up to 14 days after Procedure]
Secondary outcome measures (7)
  • Complete resection rate (endoscopic) [Time frame: up to 14 days after Procedure till histopathological results]
  • Clinical success rate (curative resection according to standard of care guidelines) [Time frame: up to 14 days after Procedure till histopathological results]
  • Enhances clinical success rate (no curative resection according to standard of care guidelines, but no further treatment necessary (after individual discussion of cases in tumorboard) [Time frame: about 4 weeks after the ESD]
  • Complication rate (total) [Time frame: through study completion, an average of 1 year]
  • Contributing factors on the technical and clinical success rate originating with patient and investigator aspects [Time frame: through study completion, an average of 1 year]
  • Dissection speed and rate of complications with different ESD devices [Time frame: during the procedure / 1 day]
  • Recurrence rate after 3, 6, 12, 24 and 60 months (if available) [Time frame: through study completion, an average of 5 year]

Eligibility criteria

Inclusion criteria

  • signed consent form
  • Indication for an ESD in the oesophagus, stomach, duodenum, colon or rectum
  • Age >18 years

Exclusion criteria

  • Age < 18 years

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Germany · 1 center
  • Evangelisches Krankenhaus Düsseldorf — Düsseldorf

Identifiers

NCT: NCT06993402 · DESI

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗